TScan Therapeutics Announces Updates to its Board of Directors

Timothy Barberich retires as Chair; Stephen Biggar, M.D., Ph.D. assumes the role of Chair Mr. Nicholson has more than 35 years of pharmaceutical and biotech oncology experience. Mr. Nicholson currently serves as chairman of the board of directors for G1 Therapeutics, Day One Biopharmaceuticals and Abdera Therapeutics. He also previously served on the board of directors for Turning Point Therapeutics, Five Prime Therapeutics, Tmunity and TESARO prior to their acquisitions by large pharmaceutical companies. A ...